FDA accepts MTS amended NDA

FDA accepted for review an amended NDA from Shire (LSE:SHP; SHPGY) and Noven (NOVN) for their methylphenidate transdermal system (MTS) to treat pediatric ADHD. The specific PDUFA date is not disclosed...